Covid-19: Over 136 Crore Doses of Covishield, Covaxin Expected in Next 4 Months

This can bring respite to many states who have been complaining about facing a shortage of Covid vaccines.

Vials of Covishied vaccine. Image for representational purpose.

New Delhi: More than 136 crore Covid-19 vaccine doses are expected to be available till the end of this year, the Centre said on Friday. For the next four months, India’s vaccine programme will be accelerated by the Serum Institute of India’s (SII) Covishield and Bharat Biotech’s Covaxin.

The note titled “Covid-19 Public Health Response Pro-active, Pre-emptive and Graded Response guided by Epidemiological and Scientific Rigour” listed the details about the vaccine production targets given to MPs from the Prime Minister’s Office (PMO).

As per the note, “In August the vaccine projection of Covaxin will be 2.65 crores, Covishield will be 23 crores and total a 25.65 crore doses will be produced in the month. In September the projection of Covaxin is 3.15 crore and Covishield will be 23 crores, which in total will be 26.15 crore doses.

In October the total of 28.25 crore doses will be produced out of which Covaxin will be 5.25 crore and Covishield will be 23 crore doses.” Additionally, 28.25 crore doses will be available in November of which 5.25 crore will be of Covaxin and 23 crore of Covishield.

READ ALSO: Fresh Orders For 25 Crore of Covishield and 19 Crore of Covaxin Vaccine Doses Placed by Central Govt

In December the projection of Covaxin will be 5.25 crore and Covishield will be 23 crore doses, which in total will be 28.5 crore doses for the month. As per an advance order placed by the Centre for August to December 2021, 75 per cent of Covishield vaccine doses will be procured at Rs 215.25 per dose at a total cost of Rs 8,071.87 crore.

The note has also mentioned the government will buy 28.5 crore Covaxin doses from Bharat Biotech at Rs 225.75 per dose at a cost of Rs 6,433.87 crore.

This can bring respite to many states who have been complaining about facing a shortage of Covid vaccines. Pune City Mayor, Murlidhar Mohol on Tuesday said that the Covishield Covid vaccine is unavailable in Pune as the city did not receive its supply for the last four days.

Brihanmumbai Municipal Corporation (BMC), due to lack of vaccines, suspended the vaccination programme on Wednesday at the government vaccine centers in Mumbai.

In West Bengal too people from far-flung areas were seen queueing outside government hospitals and health care centres due to vaccine shortage.

The Centre also noted the addition of Sputnik V into its vaccine basket. The Centre expects 25 million doses to be manufactured in August, September, and October by Panacea. “Thereafter there is no clarity/visibility as it depends on the bulk to be provided by Russia for filling. So, total production for the year can be expected to be 2044.16 million doses,” the note said.

READ ALSO: Covid-19: Johnson & Johnson Applies for Emergency Use Nod for Its Single Dose Vaccine in India

On July 16, the Centre placed its largest order of 66 crore Covid-19 vaccines worth more than Rs 14 crore to procure Covishield and Covaxin shots that will help it to substantially meet the vaccine availability projections. The order was in line with the its estimate of 135 crore doses being available between August-December, stated in its affidavit submitted to the Supreme Court on June 26.

The note has also mentioned, “Human resource crunch experienced during the second wave due to shortage of doctors and healthcare workers across urban areas.”

“With an unexpected surge in cases, challenges in terms of infrastructure augmentation across the country, enhanced Oxygen supply, drugs requirement and other logistics came up,” it added. Further, the note mentioned the management of medical Oxygen and the management of drugs during the second wave.

(With ANI inputs)